Ypsomed Holding AG (FRA:OWX) 3-Year Revenue Growth Rate : 5.90% (As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG 3-Year Revenue Growth Rate?

Ypsomed Holding AG's Revenue per Share for the six months ended in Sep. 2023 was €19.49.

During the past 12 months, Ypsomed Holding AG's average Revenue per Share Growth Rate was -0.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ypsomed Holding AG was 34.00% per year. The lowest was -91.60% per year. And the median was 1.80% per year.

Competitive Comparison of Ypsomed Holding AG's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's 3-Year Revenue Growth Rate falls into.

Ypsomed Holding AG 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Ypsomed Holding AG (FRA:OWX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Ypsomed Holding AG 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ypsomed Holding AG (FRA:OWX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (FRA:OWX) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

YPSNz:UK YPSN:Switzerland

Address

Brunnmattstrasse 6, Burgdorf, CHE, 3401

Website

https://www.ypsomed.com

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (FRA:OWX) Headlines

No Headlines